Teladoc officer plans sale of 7,573 shares

Teladoc Health officer Adam Vandervoort filed a Rule 144 notice to sell 7,573 shares of common stock tied to restricted stock vesting and related tax obligations.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer for a planned sale of its common stock reported under Rule 144 on behalf of officer Adam Vandervoort. The notice covers up to 7,573 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NYSE, with a reported aggregate market value of $47,719.74. The securities to be sold arise from a restricted stock vesting on September 1, 2026, and the filer states that the sale includes an amount necessary to cover a tax obligation from the settlement of a vested equity award distribution. Over the prior three months, Vandervoort reported selling 7,906 shares of Teladoc common stock for an aggregate value of $60,299.06.

Key Figures

Shares to be sold under Rule 144: 7,573 shares Aggregate market value of planned sale: $47,719.74 Shares sold in past 3 months: 7,906 shares +3 more

6 metrics

Shares to be sold under Rule 144 7,573 shares Planned Teladoc Health common stock sale for account of Adam Vandervoort

Aggregate market value of planned sale $47,719.74 Market value for 7,573 Teladoc Health shares covered by the notice

Shares sold in past 3 months 7,906 shares Teladoc Health common stock sold on June 2, 2026 by Adam Vandervoort

Aggregate value of past 3-month sales $60,299.06 Value of 7,906 Teladoc Health shares sold on June 2, 2026

Date of restricted stock vesting September 1, 2026 Source of securities to be sold under Rule 144

Date of Rule 144 notice September 2, 2026 Filing date of the Form 144 notice for planned sales

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Adam Vandervoort"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

aggregate market value financial

"7573 | 47719.74 | 181684021"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What is Teladoc Health (TDOC) disclosing in this Form 144 filing?

The filing reports a planned Rule 144 sale of 7,573 shares of Teladoc Health common stock for the account of officer Adam Vandervoort, with the shares originating from a restricted stock vesting on September 1, 2026.

How many Teladoc Health (TDOC) shares are covered by the planned Rule 144 sale?

The notice covers up to 7,573 shares of Teladoc Health common stock, with a reported aggregate market value of $47,719.74 at the time of the Form 144 filing.

What is the source of the Teladoc (TDOC) shares to be sold by Adam Vandervoort?

The shares to be sold are tied to a restricted stock vesting on September 1, 2026, and the remarks state the sale includes an amount necessary to cover a tax obligation from a vested equity award distribution.

On which market will the Teladoc (TDOC) shares be sold according to the Form 144?

The Form 144 states that the Teladoc Health common stock is to be sold through Fidelity Brokerage Services LLC on the NYSE.

What Teladoc (TDOC) share sales has Adam Vandervoort reported in the past three months?

Over the past three months, Adam Vandervoort reported selling 7,906 shares of Teladoc Health common stock on June 2, 2026 for an aggregate value of $60,299.06.

When was the Teladoc (TDOC) Form 144 notice for Adam Vandervoort filed?

The date of notice on the Form 144 is September 2, 2026, covering planned sales of Teladoc Health common stock under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 03:57 PM Accepted by SEC EDGAR 09/02/2026 - 03:57 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001375088
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Vandervoort Adam C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7573	47719.74	181684021	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			7573	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Vandervoort 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	7906	60299.06

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adam Vandervoort
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)